nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Anaemia—Mycophenolic acid—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Verteporfin—Cough—Leflunomide—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Verteporfin—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Verteporfin—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Verteporfin—Dizziness—Pentoxifylline—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Verteporfin—Hypertension—Leflunomide—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Verteporfin—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Verteporfin—Malaise—Mycophenolic acid—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Verteporfin—Malnutrition—Lisinopril—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Verteporfin—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Verteporfin—Vertigo—Mycophenolic acid—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Verteporfin—Syncope—Mycophenolic acid—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Verteporfin—Arthralgia—Leflunomide—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Verteporfin—Chest pain—Leflunomide—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Verteporfin—Osteoarthritis—Prednisone—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Verteporfin—Constipation—Captopril—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Verteporfin—Discomfort—Leflunomide—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Verteporfin—Skin disorder—Azathioprine—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Verteporfin—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Verteporfin—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Verteporfin—Cough—Mycophenolic acid—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Verteporfin—Back pain—Lisinopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Verteporfin—Rash—Pentoxifylline—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Verteporfin—Hypertension—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Verteporfin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Verteporfin—Headache—Pentoxifylline—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Verteporfin—Feeling abnormal—Captopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Verteporfin—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Verteporfin—Chest pain—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Verteporfin—Vision blurred—Lisinopril—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Verteporfin—Asthenia—Mometasone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Verteporfin—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Verteporfin—Photosensitivity—Methotrexate—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Verteporfin—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Verteporfin—Discomfort—Mycophenolic acid—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Verteporfin—Nervous system disorder—Leflunomide—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Verteporfin—Pruritus—Mometasone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Verteporfin—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Verteporfin—Anaemia—Lisinopril—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Verteporfin—Skin disorder—Leflunomide—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Verteporfin—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Verteporfin—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Verteporfin—Body temperature increased—Captopril—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Verteporfin—Oedema—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Verteporfin—Nausea—Pentoxifylline—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Verteporfin—Malaise—Lisinopril—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Verteporfin—Vertigo—Lisinopril—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Verteporfin—Syncope—Lisinopril—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Verteporfin—Shock—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Verteporfin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Verteporfin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Verteporfin—Loss of consciousness—Lisinopril—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Verteporfin—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Verteporfin—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Verteporfin—Cough—Lisinopril—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Verteporfin—Muscular weakness—Prednisone—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Verteporfin—Visual disturbance—Methotrexate—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Verteporfin—Arthralgia—Lisinopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Verteporfin—Chest pain—Lisinopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Verteporfin—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Verteporfin—Dyspnoea—Leflunomide—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Verteporfin—Discomfort—Lisinopril—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Verteporfin—Feeling abnormal—Azathioprine—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Verteporfin—Rash—Mometasone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Verteporfin—Asthenia—Captopril—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Verteporfin—Dermatitis—Mometasone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Verteporfin—Osteoarthritis—Methotrexate—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Verteporfin—Headache—Mometasone—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Verteporfin—Oedema—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Verteporfin—Pruritus—Captopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Verteporfin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Verteporfin—Pain—Leflunomide—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Verteporfin—Constipation—Leflunomide—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Verteporfin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Verteporfin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Verteporfin—Shock—Lisinopril—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Verteporfin—Body temperature increased—Azathioprine—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Verteporfin—Skin disorder—Lisinopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Verteporfin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Verteporfin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Verteporfin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Verteporfin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Verteporfin—Feeling abnormal—Leflunomide—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Verteporfin—Nausea—Mometasone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Verteporfin—Constipation—Mycophenolic acid—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Verteporfin—Pain—Mycophenolic acid—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Verteporfin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Verteporfin—Cough—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Verteporfin—Dizziness—Captopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Verteporfin—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Verteporfin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Verteporfin—Urticaria—Leflunomide—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Verteporfin—Body temperature increased—Leflunomide—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Verteporfin—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Verteporfin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Verteporfin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Verteporfin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Verteporfin—Myocardial infarction—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Verteporfin—Hypersensitivity—Azathioprine—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Verteporfin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Verteporfin—Dyspnoea—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Verteporfin—Rash—Captopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Verteporfin—Dermatitis—Captopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Verteporfin—Headache—Captopril—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Verteporfin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Verteporfin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Verteporfin—Shock—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Verteporfin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Verteporfin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Verteporfin—Pain—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Verteporfin—Constipation—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Verteporfin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Verteporfin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Verteporfin—Haemoglobin—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Verteporfin—Nausea—Captopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Verteporfin—Haemorrhage—Prednisone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Verteporfin—Asthenia—Leflunomide—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Verteporfin—Feeling abnormal—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Verteporfin—Pruritus—Leflunomide—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Verteporfin—Dizziness—Azathioprine—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Verteporfin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Verteporfin—Asthenia—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Verteporfin—Urticaria—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Verteporfin—Body temperature increased—Lisinopril—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Verteporfin—Pruritus—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Verteporfin—Pneumonia—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Verteporfin—Eye disorder—Prednisone—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Verteporfin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Verteporfin—Rash—Azathioprine—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Verteporfin—Dermatitis—Azathioprine—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Verteporfin—Flushing—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Verteporfin—Headache—Azathioprine—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Verteporfin—Dizziness—Leflunomide—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Verteporfin—Angiopathy—Prednisone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Verteporfin—Conjunctivitis—Methotrexate—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Verteporfin—Immune system disorder—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Verteporfin—Pain—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Verteporfin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Verteporfin—Sweating—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Verteporfin—Hypersensitivity—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Verteporfin—Dizziness—Mycophenolic acid—systemic scleroderma	0.001	0.001	CcSEcCtD
Verteporfin—Rash—Leflunomide—systemic scleroderma	0.001	0.001	CcSEcCtD
Verteporfin—Dermatitis—Leflunomide—systemic scleroderma	0.001	0.001	CcSEcCtD
Verteporfin—Nausea—Azathioprine—systemic scleroderma	0.001	0.001	CcSEcCtD
Verteporfin—Headache—Leflunomide—systemic scleroderma	0.000997	0.000997	CcSEcCtD
Verteporfin—Malnutrition—Prednisone—systemic scleroderma	0.000996	0.000996	CcSEcCtD
Verteporfin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000988	0.000988	CcSEcCtD
Verteporfin—Asthenia—Lisinopril—systemic scleroderma	0.000982	0.000982	CcSEcCtD
Verteporfin—Pruritus—Lisinopril—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Verteporfin—Haemoglobin—Methotrexate—systemic scleroderma	0.000961	0.000961	CcSEcCtD
Verteporfin—Rash—Mycophenolic acid—systemic scleroderma	0.000958	0.000958	CcSEcCtD
Verteporfin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000957	0.000957	CcSEcCtD
Verteporfin—Haemorrhage—Methotrexate—systemic scleroderma	0.000956	0.000956	CcSEcCtD
Verteporfin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000952	0.000952	CcSEcCtD
Verteporfin—Headache—Mycophenolic acid—systemic scleroderma	0.000951	0.000951	CcSEcCtD
Verteporfin—Pharyngitis—Methotrexate—systemic scleroderma	0.000949	0.000949	CcSEcCtD
Verteporfin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000948	0.000948	CcSEcCtD
Verteporfin—Nausea—Leflunomide—systemic scleroderma	0.000946	0.000946	CcSEcCtD
Verteporfin—Vision blurred—Prednisone—systemic scleroderma	0.000938	0.000938	CcSEcCtD
Verteporfin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000924	0.000924	CcSEcCtD
Verteporfin—Visual impairment—Methotrexate—systemic scleroderma	0.000921	0.000921	CcSEcCtD
Verteporfin—Anaemia—Prednisone—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Verteporfin—Dizziness—Lisinopril—systemic scleroderma	0.000905	0.000905	CcSEcCtD
Verteporfin—Nausea—Mycophenolic acid—systemic scleroderma	0.000902	0.000902	CcSEcCtD
Verteporfin—Malaise—Prednisone—systemic scleroderma	0.000898	0.000898	CcSEcCtD
Verteporfin—Vertigo—Prednisone—systemic scleroderma	0.000894	0.000894	CcSEcCtD
Verteporfin—Eye disorder—Methotrexate—systemic scleroderma	0.000893	0.000893	CcSEcCtD
Verteporfin—Syncope—Prednisone—systemic scleroderma	0.000893	0.000893	CcSEcCtD
Verteporfin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000887	0.000887	CcSEcCtD
Verteporfin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000883	0.000883	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisone—systemic scleroderma	0.000875	0.000875	CcSEcCtD
Verteporfin—Angiopathy—Methotrexate—systemic scleroderma	0.000867	0.000867	CcSEcCtD
Verteporfin—Immune system disorder—Methotrexate—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Verteporfin—Rash—Lisinopril—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Verteporfin—Dermatitis—Lisinopril—systemic scleroderma	0.000862	0.000862	CcSEcCtD
Verteporfin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00086	0.00086	CcSEcCtD
Verteporfin—Hypertension—Prednisone—systemic scleroderma	0.000859	0.000859	CcSEcCtD
Verteporfin—Headache—Lisinopril—systemic scleroderma	0.000857	0.000857	CcSEcCtD
Verteporfin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Verteporfin—Arthralgia—Prednisone—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000842	0.000842	CcSEcCtD
Verteporfin—Discomfort—Prednisone—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Verteporfin—Malnutrition—Methotrexate—systemic scleroderma	0.000832	0.000832	CcSEcCtD
Verteporfin—Nausea—Lisinopril—systemic scleroderma	0.000813	0.000813	CcSEcCtD
Verteporfin—Oedema—Prednisone—systemic scleroderma	0.000812	0.000812	CcSEcCtD
Verteporfin—Back pain—Methotrexate—systemic scleroderma	0.000805	0.000805	CcSEcCtD
Verteporfin—Shock—Prednisone—systemic scleroderma	0.000799	0.000799	CcSEcCtD
Verteporfin—Nervous system disorder—Prednisone—systemic scleroderma	0.000797	0.000797	CcSEcCtD
Verteporfin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000793	0.000793	CcSEcCtD
Verteporfin—Skin disorder—Prednisone—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Verteporfin—Vision blurred—Methotrexate—systemic scleroderma	0.000784	0.000784	CcSEcCtD
Verteporfin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Verteporfin—Anaemia—Methotrexate—systemic scleroderma	0.000769	0.000769	CcSEcCtD
Verteporfin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000756	0.000756	CcSEcCtD
Verteporfin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000755	0.000755	CcSEcCtD
Verteporfin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Verteporfin—Malaise—Methotrexate—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Verteporfin—Vertigo—Methotrexate—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00074	0.00074	CcSEcCtD
Verteporfin—Cough—Methotrexate—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Verteporfin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Verteporfin—Arthralgia—Methotrexate—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Verteporfin—Chest pain—Methotrexate—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000703	0.000703	CcSEcCtD
Verteporfin—Discomfort—Methotrexate—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Verteporfin—Constipation—Prednisone—systemic scleroderma	0.000695	0.000695	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisone—systemic scleroderma	0.00067	0.00067	CcSEcCtD
Verteporfin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000666	0.000666	CcSEcCtD
Verteporfin—Skin disorder—Methotrexate—systemic scleroderma	0.00066	0.00066	CcSEcCtD
Verteporfin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000656	0.000656	CcSEcCtD
Verteporfin—Urticaria—Prednisone—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Verteporfin—Body temperature increased—Prednisone—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Verteporfin—Dyspnoea—Methotrexate—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisone—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000586	0.000586	CcSEcCtD
Verteporfin—Asthenia—Prednisone—systemic scleroderma	0.000583	0.000583	CcSEcCtD
Verteporfin—Pain—Methotrexate—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Verteporfin—Pruritus—Prednisone—systemic scleroderma	0.000575	0.000575	CcSEcCtD
Verteporfin—Feeling abnormal—Methotrexate—systemic scleroderma	0.00056	0.00056	CcSEcCtD
Verteporfin—Urticaria—Methotrexate—systemic scleroderma	0.000539	0.000539	CcSEcCtD
Verteporfin—Dizziness—Prednisone—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Verteporfin—Body temperature increased—Methotrexate—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Verteporfin—Rash—Prednisone—systemic scleroderma	0.000512	0.000512	CcSEcCtD
Verteporfin—Dermatitis—Prednisone—systemic scleroderma	0.000512	0.000512	CcSEcCtD
Verteporfin—Headache—Prednisone—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Verteporfin—Hypersensitivity—Methotrexate—systemic scleroderma	0.0005	0.0005	CcSEcCtD
Verteporfin—Asthenia—Methotrexate—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Verteporfin—Nausea—Prednisone—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Verteporfin—Pruritus—Methotrexate—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Verteporfin—Dizziness—Methotrexate—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Verteporfin—Rash—Methotrexate—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Verteporfin—Dermatitis—Methotrexate—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Verteporfin—Headache—Methotrexate—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Verteporfin—Nausea—Methotrexate—systemic scleroderma	0.000403	0.000403	CcSEcCtD
